Rotavirus disease and prevention through vaccination

Pediatric Infectious Disease Journal

Volumn 28, Issue 4, 2009, Pages 351-364

  Marshall, Gary S ^a,b  

^a University of Louisville School of Medicine   (United States)

^b NONE   (United States)

Author keywords

Gastroenteritis; Rotavirus; RV1; RV5

Indexed keywords

PLACEBO; ROTAVIRUS VACCINE;

ACUTE GASTROENTERITIS; DEATH; DEVELOPING COUNTRY; DIARRHEA; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; FEVER; FLATULENCE; GASTROENTERITIS; HEMATOCHEZIA; HUMAN; HUMAN ROTAVIRUS; IMMUNIZATION; INNATE IMMUNITY; INTUSSUSCEPTION; IRRITABILITY; MORBIDITY; MORTALITY; PATHOGENESIS; PNEUMONIA; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; UNITED STATES; VACCINATION; VACCINE PRODUCTION; VIRUS INFECTION; VOMITING; ARTICLE; CHILD; GENETICS; IMMUNOLOGY; ROTAVIRUS; ULTRASTRUCTURE; VIROLOGY;

CHILD; HUMANS; ROTAVIRUS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES;

EID: 65649100841     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e318199494a     Document Type: Review

References (38)

1. Anderson EJ, Weber SG. Rotavirus infection in adults. Lancet Infect Dis. 2004;4:91-99.
2. Kapikian AZ, Hoshino Y, Chanoock RM. Rotaviruses. In: Knipe DM, Howley PM, eds. Fields Virology. Philadelphia, PA: Lippincott Williams and Wilkins; 2001:1787-1808.
3. Offit PA, Clark HF. Rotavirus. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Disease. Philadelphia, PA: Churchill Livingstone; 2000:1696 -1703.
4. Santos N, Hoshino Y. Global distribution of rotavirus serotypes/genotypes and its implications for the development and implementation of an effective rotavirus vaccine. Rev Med Virol. 2005;15:29 -56.
5. Griffin DD, Kirkwood CD, Parashar UD, et al. Surveillance of rotavirus strains in the United States: identification of unusual strains. J Clin Microbiol. 2000;38:2784 -2787.
6. Jiang B, Gentsch JR, Glass RI. The role of serum antibodies in the protection against rotavirus disease: an overview. Clin Infect Dis. 2002;34: 1351-1361.
7. Musher DM, Musher BL. Contagious acute gastrointestinal infections. N Engl J Med. 2004;351:2417-2427.
8. Coffin SE, Elser J, Marchant C, et al. Impact of acute rotavirus gastroenteritis on pediatric outpatient practices in the United States. Pediatr Infect Dis J. 2006;25:584 -589.
9. Parashar UD, Hummelman EG, Bresee JS, et al. Global illness and death caused by rotavirus disease in children. Emerg Infect Dis. 2003;9:565-572.
10. Pickering LK, Bartlett AV, Reves RR, et al. Asymptomatic excretion of rotavirus before and after rotavirus diarrhea in children in day care centers. J Pediatr. 1988;112:361-365.
11. Parashar UD, Alexander JP, Glass RI, Advisory Committee on Immunization Practices (ACIP), Centers for Disease Control and Prevention. Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2006;55(RR-12):1-13.
12. Charles MD, Holman RC, Curns AT, et al. Hospitalizations associated with rotavirus gastroenteritis in the United States, 1993 to 2002. Pediatr Infect Dis J. 2006;25:489-493.
13. Maleck MA, Curns AT, Holman RC, et al. Diarrhea- and rotavirusassociated hospitalization among children less than 5 years of age: United States, 1997 and 2000. Pediatrics. 2006;117:1887-1892.
14. Dennehy PH, Cortese MM, Begue RE, et al. A case-control study to determine risk factors for hospitalization for rotavirus gastroenteritis in US children. Pediatr Infect Dis J. 2006;25:1123-1131.
15. Török TJ, Kilgore PE, Clarke MJ, et al. Visualizing geographic and temporal trends in rotavirus activity in the United States, 1991 to 1996. Pediatr Infect Dis J. 1997;16:941-945.
16. Matson DO, Estes MK, Burns JW, et al. Serotype variation of human group A rotaviruses in two regions of the USA. J Infect Dis. 199;162:605- 614.
17. Velazquez FR, Matson DO, Calva JJ, et al. Rotavirus infection in infants as protection against subsequent infections. N Engl J Med. 1996;335:1022- 1028.
18. RotaShield prescribing information. Philadelphia, PA: Wyeth-Ayerst; August 1998.
19. Centers for Disease Control and Prevention. Suspension of rotavirus vaccine after reports of intussusception-United States, 1999. MMWR. 2004; 53:786 -789.
20. Murphy TV, Gargiullo PM, Massoudi MS, et al. Intussusception among infants given an oral rotavirus vaccine. N Engl J Med. 2001;344:564 -572.
21. Kramarz P, France EK, DeStefano F, et al. Population-based study of rotavirus vaccination and intussusception. Pediatr Infect Dis J. 2001;20: 410-416.
22. Simonsen L, Viboud C, Elixhauser A, et al. More on RotaShield and intussusception: the role of age at the time of vaccination. J Infect Dis. 2005;192(suppl 1):S36 -S43.
23. RotaTeq prescribing information. Whitehouse Station, NJ: Merck and Co. Inc; 2008.
24. Rotarix prescribing information. Research Triangle Park, NC: GlaxoSmith- Kline; 2008.
25. Vesikari T, Matson DO, Dennehy P, et al; the Rotavirus Efficacy and Safety Trial Study Team. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006;354:23-33.
26. Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, et al; Human Rotavirus Vaccine Study Group. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006;354:11-22.
27. Vesikari T, Karvonen A, Prymula R, et al. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants, randomized, double-blind controlled study. Lancet. 2007; 370:1757-1763.
28. Marshall GS. Rotavirus vaccines. Vaccine Quart. 2008;2:17.
29. Centers for Disease Control and Prevention. Delayed onset and diminish magnitude of rotavirus activity-United States, November 2007-May 2008. MMWR. 2008;57:697-700.
30. Clark HF, Lawley D, Mallette L, et al. Decline in rotavirus (RV) gastroenteritis (GE) presenting to the Children's Hospital of Philadelphia (CHOP) after introduction of pentavalent rotavirus vaccine (PRV). Poster (G1-413) presented at ICAAC/IDSA Meeting; October 2008; Washington, DC.
31. Daskalaki I, Wood SJ, Inumerable YM, et al. Epidemiology of rotavirusassociated hospitalizations pre- and post-implementation of immunization: North Philadelphia, 2000-2008. Poster (G1-432) presented at ICAAC/ IDSA Meeting; October 2008; Washington, DC.
32. Harrison CJ, Jackson M, Olson-Burgess C, et al. Fewer 2008 hospitalizations for rotavirus (RV) in Kansas City, two years post RV vaccine. Poster (G1-435) presented at ICAAC/IDSA Meeting; October 2008; Washington, DC.
33. Hatch S, Fontecchio S, Gibson L, et al. Rapid decline in pediatric rotavirus cases following introduction of rotavirus vaccine. Poster (G1-436) presented at ICAAC/IDSA Meeting; October 2008; Washington, DC.
34. Lieberman JM, Huang X, Koski E, et al. Decline in rotavirus cases in the US after licensure of a live, oral rotavirus vaccine. Poster (G1-437) presented at ICAAC/IDSA Meeting; October 2008; Washington, DC.
35. Patel JA, Loeffelholz M. Reduction of severe rotavirus gastroenteritis following the routine use of live, oral, pentavalent rotavirus vaccine. Poster (G1-434) presented at ICAAC/IDSA Meeting; October 2008; Washington, DC.
36. Mast T, Wang F, Goli V, et al. Post-licensure effectiveness of RotaTeq in preventing gastroenteritis. Poster (G1-433) presented at ICAAC/IDSA Meeting; October 2008; Washington, DC.
37. Centers for Disease Control and Prevention. Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 2009;58(RR- 2):1-25.
38. Rotavirus vaccination coverage and adherence to the Advisory Committee on Immunization Practice (ACIP)-recommended vaccination schedule- United States, February 2006-May 2007. MMWR. 2008;57:398-401.